Continuous Manufacturing and Influence of Excipient Variation

10:55 - 11:30

Batch-to-batch and vendor-to-vendor excipient variation has been studied commonly, but typically small data sets are used in literature (eg: Gamble, 2010; Doelker, 1993; Williams, 1997). Few researchers have evaluated the use of large data sets to assess the impact of excipient variation on drug product performance. In this presentation DFE Pharma shows the impact of excipient variation on continuous processes like continuous feeding, granulation and tableting.

Please note that this will be a remote presentation

Mara van Haandel, Innovation Manager, DFE pharma